French REITS Stock News

Why JCDecaux is Back on Watchlists JCDecaux (ENXTPA:DEC) has drawn fresh attention after recent share price moves, with the stock showing positive total returns over the past month, past 3 months and year. This has prompted a closer look at its fundamentals. See our latest analysis for JCDecaux. The recent share price around €18.9 sits against a backdrop of a 22.57% year to date share price return and a 24.69% total shareholder return over the past year, suggesting momentum has been building...

Guidance confirmation and Q1 update Safran (ENXTPA:SAF) confirmed its full year 2026 earnings guidance, stating that it expects low to mid teens revenue growth. The company also reported first quarter consolidated revenue of €8,624 million, compared with €7,257 million a year earlier. See our latest analysis for Safran. Safran's confirmation of low to mid teens revenue growth for 2026 and its first quarter revenue of €8,624 million come as the stock trades at €273.0, with a 1 year total...

In April 2026, ERAMET S.A. reported first-quarter production results showing weaker manganese ore and mineral sands output but very large growth in lithium carbonate volumes, alongside modest gains in manganese alloys and nickel ore. The company also issued 2026 production guidance that highlights constrained nickel ore output pending regulatory approvals, while targeting higher lithium carbonate production. Against this backdrop, we will examine how the sharp increase in lithium carbonate...

As the European markets navigate a landscape of stalled geopolitical negotiations and fluctuating oil prices, the pan-European STOXX Europe 600 Index has remained relatively stable, with corporate earnings showing signs of positive momentum. In this environment, identifying stocks that might be trading below their fair value can be particularly appealing to investors seeking opportunities amidst broader economic uncertainties.

As the pan-European STOXX Europe 600 Index remains relatively flat, with modest gains in some major markets, investors are navigating a landscape marked by cautious optimism amid geopolitical uncertainties and fluctuating oil prices. In such an environment, identifying stocks with strong fundamentals and potential for growth can offer valuable opportunities for those looking to capitalize on Europe's evolving market dynamics.

As the pan-European STOXX Europe 600 Index remains largely stable amidst a backdrop of stalled geopolitical negotiations and fluctuating oil prices, investors are keenly observing the region's economic indicators, such as Germany's rising inflation and Spain's unemployment rates. In this environment, dividend stocks can offer a measure of stability and income potential, making them an attractive option for those looking to navigate uncertain market conditions while potentially benefiting from...

If you are wondering whether Carmila's current share price reflects its underlying worth, this article walks through the key signals you can use to judge the stock's value. Carmila's share price recently closed at €16.98, with returns of 1.1% year to date and a 5.2% decline over the past year that sits alongside a 40.2% gain over three years and 73.0% over five years. Recent coverage has focused on Carmila's position in the French retail real estate market and how its portfolio is adapting...

Shareholders appeared unconcerned with Sanofi's ( EPA:SAN ) lackluster earnings report last week. We think that the...

Why Fitch’s Investment Grade Rating Matters For SPIE (ENXTPA:SPIE) Fitch’s upgrade of SPIE to Investment Grade at BBB minus puts the group in a different category for creditors, with potentially broader access to capital markets and more favorable financing terms. For you as a shareholder or prospective investor, this kind of rating shift often influences how comfortably lenders, bond buyers, and some institutional investors can engage with the company. Investment mandates and risk limits are...

bioMérieux (ENXTPA:BIM) has put fresh data on the table, with a new Office of Health Economics study linking its fast ID/AST diagnostics to fewer sepsis cases and lower treatment costs across G7 health systems. See our latest analysis for bioMérieux. The new sepsis data lands at a time when bioMérieux’s €71.7 share price has a 1 day share price return of 5.05%, but a 30 day share price return of 23.44% decline and a 1 year total shareholder return of 39.10% decline, pointing to pressure that...

Sartorius Stedim Biotech reported its first-quarter 2026 results, with sales of €761.5 million and net income of €88.1 million, and confirmed its full-year 2026 constant-currency sales growth guidance of around 5% to 9%. The combination of modest year-on-year improvements in revenue and earnings with reiterated guidance signals management’s confidence in operational momentum and demand visibility. Next, we’ll examine how this guidance confirmation, alongside incremental Q1 profit growth,...

Inventiva (ENXTPA:IVA) reshaped its leadership team, appointing a new Chief Financial Officer, Chief Legal Officer, and Chief People Officer as it prepares for a key Phase 3 NATiV3 data readout later this year. See our latest analysis for Inventiva. The latest leadership reshuffle comes as the share price sits at €4.31, with a 6.55% year to date share price return but a 16.15% decline over 90 days. At the same time, the 1 year total shareholder return of 33.02% and 3 year total shareholder...

Voltalia (ENXTPA:VLTSA) has just released first quarter 2026 figures, reporting renewable production of 1,105 GWh compared with 1,121 GWh a year earlier, while revenue reached €133.3 million compared with €107.3 million. See our latest analysis for Voltalia. Despite the solid first quarter revenue figure, Voltalia’s share price return over the year has been weak, with a year to date share price decline of 13.53% and a 1 year total shareholder return decline of 5.65%. This points to fading...

Why Ayvens’ Q1 earnings matter for shareholders Ayvens (ENXTPA:AYV) released first quarter 2026 results with sales of €2,810.8 million, compared with €2,846.3 million a year earlier, while net income was €266.5 million versus €219.9 million, drawing fresh attention to the stock. See our latest analysis for Ayvens. The Q1 earnings release appears to have reset sentiment, with the latest 1 day share price return of 5.13% and 1 month share price return of 9.75% contrasting with a 90 day share...

In its Q1 2026 earnings call on 30 April, TF1 reported a 5% revenue decline but highlighted resilient operations and a solid financial footing. A standout detail was the 22% year-on-year jump in TF1+ digital advertising revenue, helping lift total digital revenue by 18% and underscoring the importance of its Netflix tie-up and SME-focused ad tools. We’ll now examine how TF1’s strong TF1+ digital advertising growth might reshape the existing investment narrative around the group. Invest in...

Capgemini (ENXTPA:CAP) just released its Q1 2026 trading update, reporting revenue of €5,943 million versus €5,553 million a year earlier, supported by multi year cloud, AI and McDonald’s partnership deals. See our latest analysis for Capgemini. Despite the Q1 update and new cloud and AI agreements, momentum in Capgemini’s share price has been weak, with a 90 day share price return of a 23.31% decline and a 1 year total shareholder return of a 26.08% decline. This suggests investors are still...

Dassault Systèmes (ENXTPA:DSY) has been in focus after reporting first quarter 2026 earnings and reaffirming full year revenue and EPS guidance, alongside a new partnership with OMRON in production system simulation and automation. See our latest analysis for Dassault Systèmes. Those Q1 results and the OMRON collaboration come after a mixed run in the share price, with an 8.37% 1 month share price return contrasting with a 17.59% 3 month decline and a 42.31% 1 year total shareholder return...

Etablissements Maurel & Prom (ENXTPA:MAU) has updated investors on its Sinu-9 gas licence drilling in Colombia, highlighting gas discoveries across several formations in the Hechicero-1X well and reporting strong initial test rates. See our latest analysis for Etablissements Maurel & Prom. The latest Sinu-9 update comes after a strong run in the share price, with a 90 day share price return of 51.95% and a one year total shareholder return of 130.78%, suggesting momentum has been building...

Why Virbac Stock Is On Investors’ Radar Now Virbac (ENXTPA:VIRP) has drawn attention after a steady share price near €371.50, with returns of about 6% over the past month and past 3 months, and 19% over the past year. See our latest analysis for Virbac. Recent trading reflects a mix of short term consolidation and longer term strength, with a 1 day share price return of 2.34% set against a 1 year total shareholder return of 18.66% as sentiment around Virbac’s prospects adjusts. If Virbac’s...

Why SES Stock Is On Investors’ Radar Today SES (ENXTPA:SESG) has been drawing fresh attention after a solid run over the past year, with the share price showing gains over the past month, past 3 months and year to date. See our latest analysis for SES. The recent momentum in SES is hard to ignore, with a 30 day share price return of 10.71% and a year to date share price return of 23.66%. The 1 year total shareholder return of 65.42% highlights how dividends and other distributions have added...

Verallia Société Anonyme (ENXTPA:VRLA) has drawn investor attention after its AGM approved a reduced dividend of €1 per share for 2025, giving shareholders a choice between cash or stock. See our latest analysis for Verallia Société Anonyme. Alongside the lower dividend, Verallia Société Anonyme has seen a 14.69% 1 month share price return to €20.38, yet its 1 year total shareholder return of 26.38% decline suggests longer term momentum has been fading. If this dividend decision has you...

On 21 April 2026, Vusion S.A. confirmed its 2026 group earnings guidance, forecasting total value-added services (VAS) revenue to rise by around 40%, driven by both recurring and non-recurring VAS momentum. This emphasis on fast-growing, higher-margin VAS underlines a shift in Vusion’s revenue mix toward more service-oriented, potentially stickier customer relationships. With this stronger VAS growth outlook now on the table, we’ll examine how it reshapes Vusion’s investment narrative and...

Wondering whether Clariane at around €4.04 is a bargain or a value trap? This article breaks down what the current share price may be implying about the business. The stock has been relatively flat over the last 7 days with a 0.2% return. However, the 9.4% return over 30 days and 3.5% return over 1 year sit against a much weaker 3-year and 5-year record of negative 12.6% and negative 78.7% respectively. Recent coverage has focused on Clariane's position within the French healthcare sector...

Accor SA recently reported first-quarter 2026 revenue of €1,313 million, slightly below the €1,349 million recorded in the same period a year earlier. Alongside this softer revenue print, Accor and partners are pushing into India’s lifestyle segment with The Hoxton, Bengaluru City, scheduled to open in November 2026. Next, we’ll examine how the softer first-quarter revenue figure shapes Accor’s investment narrative built around asset-light expansion and earnings quality. Capitalize on the AI...